ICU Medical (ICUI) Tops Q4 EPS by 4c; Offers FY23 EPS Guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.60, $0.04 better than the analyst estimate of $1.56. Revenue for the quarter came in at $578 million versus the consensus estimate of $578.77 million.

GUIDANCE:

ICU Medical sees FY2023 EPS of $5.75-$7.25, versus the consensus of $7.22.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Voya Financial warns shareholders about unsanctioned TCIM straw poll
• BlackBerry (BB) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance